Quanterix to Present at Cowen’s 43rd Annual Health Care Conference
Cowen’s 43rd Annual
To access the live audio webcast of Quanterix’s presentation at the conference, please visit: https://wsw.com/webcast/cowen132/qtrx/2062158. Quanterix’s session will take place on
Replays of the presentation will be available for a limited period following the conference. The presentation will also be made available through the Investor Relations section of Quanterix’s website.
To learn more about
From discovery to diagnostics, Quanterix’s ultrasensitive biomarker detection is fueling breakthroughs only made possible through its unparalleled sensitivity and flexibility. The Company’s Simoa® technology has delivered the gold standard for earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the Limit of Quantification (LoQ) of conventional analog methods. Its industry-leading precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230228006341/en/
Investor Relations Contact: